Drug discovery

How iPSC-derived 3D organoids and high-throughput histology opens a new door to personalized medicine development and testing.

How a new compound promises to selectively activate hepatic glucokinase in a bid to treat type 2 diabetes.

A novel protein platform helps neutralize powerful MRSA toxins.

Seeking inspiration from plants in the fight against Alzheimer’s disease.

How DNA origami nanostructures could find their way into the treatment of acute kidney injury.

Two chemical components; opposite effects. How medical marijuana impacts glaucoma for better – and for worse.

Sitting Down With… Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland.

A new method for discovering antibiotics makes use of an unusual source of complex microbial communities: bear saliva.

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.